OSE Immunotherapeutics Identifies Monoclonal Antibody Antagonists of CLEC-1 as New Checkpoint Inhibitors of Immune Myeloid Cells in Immuno-Oncology

NEXT STORY
Revive Therapeutics Provides Update on Discussions with Health Canada in Pre-CTA Meeting
PREV STORY
Global Bio safety Testing Market is Estimated to be US$ 10.5 Billion by 2029 with a CAGR of 13.1% during the forecast Period – PMI
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Midatech Pharma PLC: Trading Update

 25 July 2018 Midatech Pharma PLC(“Midatech”, “Company” or “Group”) Trading Update Midatech Pharma (AIM: ...

author_avatar
NASDAQ Market News

electroCore, Inc. Announces Additions to Board of Directors in Connection with Recently Completed Initial Public Offering

BASKING RIDGE, N.J., July 10, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq:ECOR), a ...

author_avatar
NASDAQ Market News

Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine

– Marked and Durable Responses Across TRK Fusion Cancers – – 75 Percent Overall ...

author_avatar
NASDAQ Market News